CNS-Penetrant TYK Inhibitors: Addressing Translational Challenges in Neuroinflammation
Time: 9:30 am
day: Conference Day Two
Details:
- Delving into genetic and pharmacologic rationale for TYK2 inhibition in multiple sclerosis
- Highlighting key neuroinflammatory and neurodegeneration-associated cell types and signaling pathways modulated by TYK inhibitors
- Conducting in vivo confirmation of CNS penetration and activity in CNS disease models
